A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Abstract Background A detailed understanding of the pathological processes involved in genetic frontotemporal dementia is critical in order to provide the patients with an optimal future treatment. Protein levels in CSF have the potential to reflect different pathophysiological processes in the brai...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sofia Bergström, Linn Öijerstedt, Julia Remnestål, Jennie Olofsson, Abbe Ullgren, Harro Seelaar, John C. van Swieten, Matthis Synofzik, Raquel Sanchez-Valle, Fermin Moreno, Elizabeth Finger, Mario Masellis, Carmela Tartaglia, Rik Vandenberghe, Robert Laforce, Daniela Galimberti, Barbara Borroni, Chris R. Butler, Alexander Gerhard, Simon Ducharme, Jonathan D. Rohrer, Anna Månberg, Caroline Graff, Peter Nilsson, on behalf of the Genetic Frontotemporal Dementia Initiative (GENFI)
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Cerebrospinal fluid
Neurofilament medium polypeptide (NEFM)
Neuronal pentraxin 2 (NPTX2)
Neurosecretory protein VGF (VGF)
Aquaporin 4 (AQP4)
LASSO
Neurology. Diseases of the nervous system
RC346-429
Geriatrics
RC952-954.6
Accès en ligne:https://doaj.org/article/4c79ff7f1a074b35826ced4f2779339c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/4c79ff7f1a074b35826ced4f2779339c

Documents similaires